124 related articles for article (PubMed ID: 11527143)
1. Prevention of stress-induced hypertension in hypertensive patients.
Salvador M; Chamontin B; Begasse F; Amar J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S90-4. PubMed ID: 11527143
[TBL] [Abstract][Full Text] [Related]
2. [Outcome of "white coat reaction" induced by nurse and physician in patients with hypertension treated with a beta blockader (bisoprolol)].
Salvador M; Chamontin B; Begasse F; Guittard J
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1115-8. PubMed ID: 1979728
[TBL] [Abstract][Full Text] [Related]
3. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
Bouvier JM; Rabot D; Herrero G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
[TBL] [Abstract][Full Text] [Related]
4. Age dependence of therapy result and risk in the treatment of arterial hypertension?
Höffler D; Morgenstern HO
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
[TBL] [Abstract][Full Text] [Related]
5. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
[TBL] [Abstract][Full Text] [Related]
6. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
[TBL] [Abstract][Full Text] [Related]
7. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
Oliván Martinez J; Garcia MJ; Rodriguez Botaro A; Pizarro JL; Carretero J; Garrido M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S95-9. PubMed ID: 11527144
[TBL] [Abstract][Full Text] [Related]
8. A study of the white-coat phenomenon in patients with primary hypertension.
Zhu N; Bu M; Chen D; Li T; Qian J; Yu Q; Chen Q; Wan C; Qu H; Zhu M; Zou X
Hypertens Res; 2008 Jan; 31(1):37-41. PubMed ID: 18360016
[TBL] [Abstract][Full Text] [Related]
9. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
10. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular reactivity to and renal impact of stress and exercise: effects of bisoprolol.
Fauvel JP; Hadj-Aissa A; Laville M; Pozet N; Bernard N; Sassard J; Zech P
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S19-24. PubMed ID: 11527127
[TBL] [Abstract][Full Text] [Related]
12. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
[TBL] [Abstract][Full Text] [Related]
14. [Atenolol and bisoprolol in the treatment of mild and moderately severe hypertension].
Soucek M; Prásek J; Spinarová L
Vnitr Lek; 1993 Jun; 39(6):541-8. PubMed ID: 8212607
[TBL] [Abstract][Full Text] [Related]
15. [Bisoprolol in the treatment of hypertension].
Spinar J; Zicha J; Vítovec J
Vnitr Lek; 1993 Sep; 39(9):865-70. PubMed ID: 8212640
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
18. The 'ABPM effect' gradually decreases but does not disappear in successive sessions of ambulatory monitoring.
Calvo C; Hermida RC; Ayala DE; López JE; Fernández JR; Domínguez MJ; Mojón A; Covelo M
J Hypertens; 2003 Dec; 21(12):2265-73. PubMed ID: 14654746
[TBL] [Abstract][Full Text] [Related]
19. Three years of experience with bisoprolol in the treatment of mild to moderate hypertension.
Giesecke HG; Buchner-Möll D
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S175-8. PubMed ID: 11527123
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
